Colossal developed a first-of-its-kind mammalian cloning method from blood samples, eliminating the need for invasive tissue collection. Born from the company’s landmark dire wolf de-extinction work, this breakthrough removes one of the biggest barriers to cloning endangered or difficult-to-sample species.